In this issue of EClinicalMedicine, Vourc\'h and colleagues [@bb0005] report the results of the PREOPTIPOP trial, the first randomized trial to compare non-invasive ventilation (NIV) versus high flow nasal cannula (HFNC) during tracheal intubation in the operating room. The trial enrolled 100 obese adults undergoing elective intubation in the operating room of a single medical center. Patients randomized to NIV received 100% oxygen with an inspiratory positive airway pressure of 15 cm H~2~O and an expiratory positive airway pressure of 5 cm H~2~O from the start of pre-oxygenation until the patient developed apnea after induction. Patients randomized to HFNC received 60 L/min of 100% oxygen via nasal prongs from the start of pre-oxygenation until intubation of the trachea. Patients randomized to NIV had higher end-tidal oxygen concentrations following intubation (88%, inter-quartile range 82% to 90% vs. 76%, inter-quartile range 66% to 82%; P \< 0.0001) and a lower incidence of arterial oxygen saturation less than 95% (30% vs. 12%; P = 0.03). The incidence of moderate or severe complications did not differ between groups. These results are consistent with those of other recent trials demonstrating the benefit of providing positive pressure during preoxygenation [@bb0010], [@bb0015] and during the period from induction to laryngoscopy [@bb0020].

High flow nasal cannula (HFNC) has been proposed for use in preoxygenation because it provides a high concentration of inhaled oxygen, decreases work of breathing, washes out anatomic dead space, and provides a low level of continuous positive airway pressure [@bb0025], [@bb0030]. Additionally, HFNC can be left in place after induction, providing "apneic oxygenation," at a time when laryngoscopy requires removal of face masks used for bag-mask ventilation or non-invasive ventilation. Trials evaluating preoxygenation and apneic oxygenation with HFNC, however, have largely shown disappointing results [@bb0035], [@bb0040], [@bb0045], particularly when HFNC is compared against NIV [@bb0050]. The higher mean airway pressures achieved by non-invasive ventilation may outweigh the potential benefits of apneic oxygenation. Alternatively, non-invasive ventilation may assist ventilation, delivering highly oxygenated air to the distal alveolar spaces more effectively than apneic oxygenation. Although incomplete, the data currently available suggest that, for many patients, positive pressure ventilation with NIV may be more effective than HFNC for preventing hypoxemia during tracheal intubation.

To our knowledge, this is the first airway management trial in which end-tidal oxygen concentration (EtO~2~) has been used as a surrogate outcome for patient oxygenation status during intubation. EtO~2~, the oxygen concentration at the end of an exhaled breath, reflects the oxygen concentration in the alveolar space, an important determinant of the arterial partial pressure of oxygen. Previous guidelines have suggested using EtO~2~ concentrations to ensure adequate preoxygenation [@bb0055]. Measuring EtO~2~ at induction, however, neglects the potential effects of preoxygenation device on functional residual capacity after induction or ongoing oxygen administration during apnea. In contrast, the PREOPTIPOP trial used the nadir in EtO~2~ that occurs following intubation as a measure of the lowest alveolar oxygen concentration during the entire intubation procedure.

There are important reasons to explore additional measures of oxygenation during intubation beyond arterial blood gas (ABG) analysis and oxygen saturation by pulse oximetry (SpO~2~). ABG\'s are invasive, slow to provide results, and may miss the nadir in oxygen content as they cannot be obtained continuously. SpO~2~ has an upper threshold at 100% when all hemoglobin is saturated with oxygen, which occurs near an arterial partial pressure of oxygen (PaO~2~) of 100 mm Hg in most patients. This means that SpO~2~ cannot detect any changes in PaO~2~ occurring from 100 mm Hg to 650 mm Hg, the range of values that typically occur during intubation in the operating room.

The nadir of EtO~2~ following intubation is related to the same variables that determine arterial oxygen content: 1) the alveolar oxygen concentration at the end of preoxygenation, 2) the volume of air in the lungs at the end of pre-oxygenation, 3) the rate of oxygen uptake (metabolic rate), and 4) the duration of apnea. As a surrogate for PaO~2~ unencumbered by the upper threshold experienced by SpO~2~, the nadir of EtO~2~ during intubation could be valuable as an outcome in populations with a low incidence of hypoxemia. However, unlike arterial measures of oxygenation, EtO~2~ concentrations are susceptible to measurement error from entrained air, and EtO~2~ concentrations at the end of intubation may be impacted by dead space to a much greater extent than EtO~2~ measured at the end of preoxygenation. Portions of the lung without perfusion (dead space) will not participate in gas exchange during the apneic period and will return highly oxygenated air that is not representative of the partial pressure of oxygen in the portions of the lung participating in gas exchange. In a trial comparing peri-intubation interventions, however, a higher EtO~2~ is still better, as the authors demonstrate by showing the correlation between end-tidal oxygen concentration and the incidence of oxygen saturation less than 95% by pulse oximetry.

In summary, the authors of the PREOPTIPOP trial are to be congratulated for conducting a rigorous study, which adds to a growing body of literature outlining the potential benefits of positive pressure ventilation during tracheal intubation. While questions remain about the best surrogate outcome for airway management research, the nadir of end-tidal oxygen provides another method of monitoring patient oxygenation during this high-risk procedure.
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